In efforts to combat the ongoing opioid crisis in America, the US House of Representatives is currently working to push through dozens of bills that many believe could help curb the rising overdose death rates and give the country a fighting chance. However, some have pointed out that Big Pharma MAT drug makers are spending millions lobbying Congress, and those same companies stand to bank big money off these new laws.
So, while we want to believe that new laws supporting Medication Assisted Treatment or “MAT” could help with harm reduction efforts, it is also good to point out that the drug companies who are positioned to benefit substantially are also those who have been racking up a lot of influence in Washington through huge donations.
In just a two week period, the House has already cleared several measures that would soon launch these MAT drug manufacturers into a sales spike.
Top MAT Drug Makers Lobbying Congress
So how much are these Big Pharma companies spending?
This biopharmaceutical company focusing mainly on central nervous system disease has already spent $1 million in lobbying. Part of that money went to support a bill that would fund full-service centers where people can:
This MAT drug maker is poised to cash in on this law because it could bolster the sales of anti-addiction injection Vivitrol. This is currently Alkermes best-selling product. However, the need for patients to fully detox before taking the drug is a limitation.
The aggressive marketing tactics this company is using, on top of their big budget for trying to influence Washington is already gaining them some attention. One thing that draws some of that attention is that the main focus of Alkermes lobbying was the bill presented by Representatives Brett Guthrie and Gene Green. Coincidentally, one of Alkermes main lobbyists served as Guthrie’s chief of staff, and another was Green’s former legislative director. Yet another example of people working in Congress making a jump to rallying government officials behind drug companies.
Guthrie and Green both reject any implication that they drafted the bill to support Alkermes. It is true that by several MAT drug makers also support their proposal.
This UK based specialty pharmaceutical company spent $180,000 on lobbying Congress. Indivior’s money went to support a bill easing restrictions on certain controlled substances used in injectable anti-opioid treatments.
Indivior rivals Vivitrol with their own product, Sublocade. This anti-addiction treatment is a once-a-month injection to fight opioid cravings. The bill they are bidding for would make it much easier for doctors to buy Sublocade for addiction treatment.
Sublocade was approved back in 2017 as an extended release buprenorphine compound. It became the first once-monthly injectable buprenorphine formulation for treating opioid use disorder (OUD).
Braburn Pharmaceuticals is an MAT drug maker from Pennsylvania that dropped a cool $100,000 along with Indivior to support the same bill for easing restrictions on controlled substances.
Braeburn is also developing a competing injectable MAT drug. But back in January, the FDA sent a complete response letter to the company. In the letter the FDA requests more data to be compiled for the therapy. The product was previously recommended for approval by the FDA’s Psychopharmacologic Drugs Advisory Committee in November 2017.
As of May 2018, Braeburn announced Phase 3 of testing on CAM2038- the buprenorphine weekly and monthly injectable- had some positive developments. The results we published online in the Journal of the American Medical Association (JAMA) Internal Medicine.
If this MAT drug does get approval, it will be the first and only injectable opioid use treatment that healthcare professionals can administer from Day 1 of patient’s treatment.
But let us not forget that each of these injectable MAT drug treatments says they should only be a part of a complete treatment program that includes counseling and psychological support.
Big Pharma Supergroup
That may not be the actual name, but it is essentially what we are talking about. A group of non-opioid pain relief drug makers has also spent hundreds of thousands of dollars on lobbying. This Big Pharma “supergroup” aims to push for legislation that will allow for additional Medicare payment for non-opioid pain drugs. One such drug company is Heron Therapeutics out of California.
Heron alone spent $40,000 from January to March lobbying on the issue of setting rates for post-surgical non-opioid drugs.
Pros and Cons
None of this is to say the MAT drug makers should not support more options for addiction treatment. There should always be support for establishing more comprehensive and inclusive treatment opportunities. In the midst of one of the most devastating drug epidemics in American history, every little bit counts. MAT programs and harm reduction can save a life and give someone an opportunity to get treatment.
But we should also be aware of how much money any drug maker is pouring into the political system in hopes of greasing the wheels of the legislative branch. When the opioid crisis became a major campaign issue, Congress used February’s budget deal to authorize $6 billion in spending to address the epidemic. That is what suddenly inspired over 300 drug companies and interest groups to rush to Capitol Hill and lobby.
Overall, the House package is something that many anti-addiction advocates and other lawmakers see as only minor progress toward addressing such a massive public health crisis. Most agree that it is important to take what steps you can. Still, many agree these efforts fall far too short of what is truly necessary in order to make an impact.
These proposals can be a good step in the right direction. MAT drug programs can be useful in giving people a chance at getting off illicit drugs. However, MAT is only one element to treatment. It is not a sustainable substitute. Hopefully, more energy and funding in the future will help create detox and treatment expansion programs. Then more people can get the help they need instead of depending on drug companies to provide them with a temporary solution to such a complex issue.
Palm Partners Recovery Center believes in providing personalized and holistic treatment options. That is why we also offer MAT programs for those in need. Recovery is never one-size-fits-all, and we strive to help each individual find the recovery plan that is right for them. If you or someone you love is struggling, please call toll-free now. We want to help.
CALL NOW 1-800-951-6135
For most, there is little doubt that the War on Drugs is an indisputable failure. It has taken an excessive amount of money, manpower, and lives with little to show for it besides one of the worst drug epidemics in the history of the country. Time has proven these policies to be ineffective and costly, so where do we go from here?
Perspective in our nation changes and the stigma attached to addiction is now being to be confronted. Along with it all comes waves of new proposals on how America’s drug policies can evolve. Which is the right way is still unclear.
Right now, while many are confused if Jeff Sessions and the Trump administration will be actively cracking down on marijuana in states with legalization laws, there are others on the federal level that are actively pushing in the opposite direction. Part of a new bill currently in the House is trying to do even more to end the War on Drugs, by directly pushing pro-pot politics.
The Marijuana Justice Act
Last August, Democratic Senator Cory Booker from New Jersey introduced the “Marijuana Justice Act of 2017”. He was joined by Democratic Representative Barbara Lee from California in bringing the reform legislation to both chambers of Congress. Historically, this was the first time a companion legislation was introduced in both chambers to remove marijuana from the Controlled Substances Act (CSA). According to early reports, as a companion to Booker’s S. 1689 is the companion bill HR 4815. These efforts are to:
- Remove marijuana from CSA
- Incentivize states to mitigate existing and ongoing racial disparities in state-level marijuana arrests
- Expunge federal convictions specific to marijuana possession
- Allow individuals currently in federal prison for marijuana-related violations to petition for resentencing
- Create community reinvestment fund to invest in communities most impacted by the War on Drugs
Currently, marijuana is in the same federal category as drugs like:
Even those who do not advocate for marijuana legalization at least see the fault in its scheduling. Trey Growdy, the Republican Representative from South Carolina has repeatedly questioned why marijuana is considered a schedule 1 drug. This schedule actually puts it above Cocaine and methamphetamines.
One of the big pieces of the bill is also that bit about expunging convictions. Justin Strekal, political director for NORML (the National Organization for the Reform of Marijuana Laws) notes that this is “the first piece of legislation that addresses expungement issues,” to clean up former criminal records for cannabis use.
Now, a new version of the bill has been introduced to the House just last week. The goal is described as a campaign against the current federal drug policy and the failed War on Drugs.
Speaking with Sponsors of Bill
Last year, after introducing his version of the bill, Senator Cory Booker stated,
“Our country’s drug laws are badly broken and need to be fixed.”
“They don’t make our communities any safer—instead they divert critical resources from fighting violent crimes, tear families apart, unfairly impact low-income communities and communities of color, and waste billions in taxpayer dollars each year.”
Booker also believes getting rid of old pot-policies of the War on Drugs would help to bolster the economy. He states,
“It’s estimated that legal cannabis in the U.S. would create $40 billion in revenue and nearly a million jobs.”
“But it’s about more than that $40 billion —it’s about equality, and getting rid of the legal past that is stifling individuals’ opportunity and their future.”
One co-sponsor for the bill is Representative Ro Khanna. He says that revenue from taxes on marijuana would then be allocated to funding the programs to reinvest in communities that were harmed by the anti-pot policies of the War on Drugs.
Representative Barbara Lee says,
“This legislation will end this destructive War on Drugs.”
This new bill to attack the War on Drugs also has the support of the Drug Policy Alliance. Kassandra Frederique, the New York States Director for the Drug Policy Alliance, states,
“This bill makes clear to state and local elected officials that they cannot move forward beyond prohibition without taking a serious look at the historical and ongoing impacts of drug war policies.”
Supporters of the bill continue to emphasize that this isn’t just about ending pot prohibition. They say it is also about putting forth resources to help communities recover.
Why are We Talking About This?
As a provider of innovative holistic treatment for drug and alcohol abuse, we pay attention to the way drug policy changes because we know how it impacts communities around the country. In order to provide help to those who need it, we have to be talking about these changes. If drug policies shift, we must talk about how they can affect those who struggle with substance use disorder.
It does not matter if a drug is an illicit black-market substance, or a popular legalized product, substance abuse and addiction are still possible. If marijuana reform is going to continue to grow, it is also our responsibility to bring attention to the possible risks and side effects for some who use marijuana.
If pro-pot politics are going to put marijuana in the mainstream, there should also be an effort to promote substance abuse treatment options. Looking back, if the War on Drugs taught us anything, it is that there should be a strong focus on providing treatment, not punishment. If we want to make things better, we have to offer every opportunity to help those who need it most.
Marijuana abuse can have a noticeable impact on some people’s lives, and often times it is accompanied by another form of substance abuse. Acknowledging the influence of drugs in your life and knowing when to get help can make the recovery process a life-changing journey. If you or someone you love is struggling with substance abuse or addiction, please call toll-free now. We want to help.
CALL NOW 1-800-951-6135
No one loves harder than a mother, and the pain a mother feels when a child suffers one cannot even imagine. So when a mother loses a child, the hurt can do a lot of things. For some mothers, it pushes them to action, and that is exactly what happens to a grieving mom in Ohio who recently launched a battle against drug overdoses with a roadside billboard after the loss of her son.
Following the overdose death of her son, Lenora Lada paid to put up a billboard in the Marietta, Ohio to raise awareness about the Good Samaritan laws. She takes this action in hopes that other mothers may not have to grieve as she does.
Trey’s Life Mattered
The sign Lada bought shows a picture of her son, Trey Moats, and reads,
“His Life Mattered: No Excuse For Not Calling 911 or taking someone to a hospital,”
Trey’s mother had known about his struggles with addiction but had felt helpless as her 26-year-old child was unwilling to get the help he needed.
Then one day at 3:26 in the morning, she got a call from her son’s friends. Trey had been in a car with these friends when his lips turned blue as he overdosed, so they had driven him to another friend’s house to ask a mother there to perform CPR. But because they were too afraid to call 911, they called Trey’s mother instead and told her to come and get him. Lenora Lada states that by the time she arrived, her son was on the ground already gurgling.
By the time Lada arrived at her son’s side, it had already been 20-25 minutes. When she asked if someone had called 911, she was told by the other mother,
“No, I don’t want the squad and the sheriffs coming to my house again.”
Lada demanded that the daughter call 911, but Moats ultimately died at the hospital of multiple organ failures due to cardiac arrest and polysubstance abuse. Ever since that tragic and heartbreaking moment, Lenora Lada is determined to make sure people know that her son’s life mattered, as do the lives of other victims of overdose. The billboard also states:
“3/10 Mile could have saved Trey’s life.”
Lada believes a call to emergency responders could have saved her son. The sheriff’s report, however, states it is unclear if her son would have survived even if he was taken to the hospital. Local news reports that one coroner said Trey would have been brain dead, but another coroner did not seem so sure.
One thing is for sure though, Trey’s life did matter. And whether or not it was certain to make a difference, something more should have been done to try and save this young man’s life. That is why now Lada is also focused on raising awareness for Good Samaritan laws in Ohio.
We would like to offer you the FREE GIFT of a checklist to help decipher if you are helping or hurting a loved one who is struggling with addiction.
Click for FREE GIFT
Good Samaritan Awareness
According to the Good Samaritan law:
- Authorities cannot prosecute anyone who calls 911 to report an overdose
- Protects the person overdosing from prosecution
- Immunity is only good two times
- The law is not applicable to people on parole
Ohio’s Good Samaritan laws also require a survivor of an overdose to obtain a drug treatment referral within 30 days in order to avoid charges. This measure is in place with hopes to show more people who do suffer from addiction there are opportunities to seek help.
The intention of Good Samaritan laws is to reduce the hesitation to get help from bystanders who witness an overdose. These laws vary from jurisdiction to jurisdiction, with different interactions with other legal principals. But in essence, they are meant to prevent unnecessary overdose deaths by trying to take the fear of punishment out of the situation.
Lada also believes she would like part of the law to be changed, stating,
“I am asking for people to be accountable for not getting them help,”
What exactly that would look like is unclear, but for a mom who lost her son, it is an understandable sentiment. In many cases, there have been voices of support for charging drug dealers who sell to overdose victims with murder. So if this were to happen, what kind of punishment should someone face for not reporting an overdose?
Good Samaritan laws exist to help prevent deaths due to drug use, and there should be more of an effort to encourage people to report overdoses. Far too many sons and daughters are lost every day to drug overdoses. We should be taking every action we can to avoid more of the same. To defeat drug-related death requires prevention, education, and effective addiction treatment. If you or someone you love is struggling, do not hesitate. Please call toll-free now. We want to help.
CALL NOW 1-800-951-6135
Author: Justin Mckibben
Deaths due to drugs like fentanyl and other synthetic opioids continue to rise at a devastating pace in America. Despite the implementation of a special opioid commission to tackle the opioid crisis head-on, and even after the President of the United States issued a public health emergency concerning this ongoing issue, drugs like fentanyl are still finding their way into the country.
So how is it that these dangerous drugs are still getting across our borders?
Mailing Law Loophole
Much of the current flow of fentanyl into America is said to be connected to a major loophole in mail security. As it stands, every day up to one million packages overall get into the US without being screened.
Under the current laws, most international packages must include some general information, such as:
- Information on the sender
- The packages destination
- Contents of the package
These seemingly simple details can, in fact, help authorities track and detect packages containing illicit substances. However, these are not bulletproof methods of detections.
A big part of the problem is a loophole that exists within our current system. According to Alex Wolff, of the bipartisan coalition Americans for Securing All Packages,
“Due to a loophole in the global postal system, packages sent via private couriers (like UPS or FedEx) are required to have the advance electronic data used by law enforcement to screen and stop dangerous material, while packages shipped via foreign postal services are not.”
Wolff explains that when materials are sent through certain channels from outside the country, they are sent without the necessary security data that law enforcement agencies require in order to screen and stop dangerous packages.
Considering that fentanyl and other synthetic opioids are expected to be produced primarily in China, much of the drug is being shipped through this international loophole right into the United States. Thus, law enforcement is essentially flying blind in their efforts to catch a lot of the drug as it slips into the country.
The STOP Act
In an effort to put an end to this exploitation of the mailing system, the Synthetics Trafficking & Overdose Prevention (STOP) Act was introduced to the Senate and House of Representatives in February of 2017. It is currently listed as H.R. 1057, as introduced by Republican Representative Patrick J. Tiberi of Ohio. This bipartisan and bicameral legislation could be a huge step forward. Sponsors for the bill include:
- Ohio Republican Senator Rob Portman
- Wisconsin Republican Senator Ron Johnson
- New Hampshire Republican Senator Kelly Ayotte
Each of these officials represents a state that has been hit hard by the opioid crisis. Surprisingly, almost a year later there has been no further action by Congress to pursue this bill.
Still, Alex Wolff remains optimistic that Congress will act soon to push the bill forward. Now the STOP Act also has the support of:
- The National Council of State Legislators
- Fraternal Order of Police
- The American Medical Association
To clarify, there are a few other prominent “STOP” Acts in the past, including:
TheSober Truth on Preventing Underage Drinking Act (STOP Act) of 2006
This was America’s first comprehensive legislation on underage drinking.
The Strengthen Opioid Misuse Prevention (STOP) Act of 2017
This was a law for North Carolina aimed at curbing the misuse and abuse of opioids.
Putting a STOP to Fentanyl Shipping
Whether having tracking information on international packages seems like a big deal or not, most experts take it very seriously. According to former assistant secretary in the Department of Homeland Security Juliette Kayyem, who is a lecturer on international security at the Harvard Kennedy School,
“You have the demand problem, the public health problem of making sure people cannot be addicted, but on the supply-chain issue, one of the loopholes is clearly the postal system,”
True, not very many drug distributors write “fragile fentanyl shipment: Handle with care” on their postage. However, Kayyem says that collecting data from senders, even those who are less likely to be truthful is important for law enforcement to be able to stop drugs like fentanyl from coming into the country. Kayyem states that even if someone from another country is shipping things in and lies about what is in the package, that lie itself becomes a means to get them in the long run.
Should this bill be pushed into action? Is this enough, or should there be a way to impose even more strict regulations on international mailing to put a stop to the exploitation of the mailing system? Is this the best way to curb fentanyl use and overdose?
In the past few years, overdose deaths due to synthetic opioids like fentanyl have skyrocketed. Over 20,145 people died from synthetic opioids other than methadone in 2016. But the opioid crisis isn’t just about preventing the drug from coming into the US. We also need to support effective addiction treatment options. If you or someone you love is struggling with substance abuse or addiction, please call toll-free now.
CALL NOW 1-800-951-6135
Author: Justin Mckibben
It seems politicians are telling people- take your pick; guns or marijuana… you can’t have both.
Back in 2016, you may recall that we did an article covering the story of S. Rowan Wilson, a Nevada resident who in 2011 was denied when attempting to purchase a handgun when the gun store owner recognized her as a medical marijuana cardholder. In court, Wilson maintained that she does not herself use marijuana, but in August of 2016, the 9th U.S. Circuit Court of Appeals decided in a 3-0 vote that if you have a medical marijuana card, you can’t buy a gun.
Recently the ideas behind this case have sparked renewed outrage and discussion over whether or not medical marijuana users should be permitted to own a firearm. The gun control debate is one that is already being consistently argued in the shadow of recent mass shootings and pushing from politicians to address the issue. But drug policy impacting gun policy adds a new perspective to the conversation.
Now there are several states cracking down on marijuana users, and it has some people up in arms about how even though states are legalizing medical marijuana use, federal law and many state governments are cutting them off from their right to gun ownership.
Under Federal Influence
According to federal law, gun purchases are already prohibited to people who are described as:
“-unlawful user and/or addict of any controlled substance.”
Back in 2011, the Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) insisted that the law applies to marijuana users-
“regardless of whether [their] State has passed legislation authorizing marijuana use for medicinal purposes.”
So it seems the ATF and the federal government are pulling out all the stops when it comes to making sure marijuana users aren’t allowed to own guns.
The decision in the care of Wilson and the 9th U.S. Circuit Court of Appeals includes the areas:
- District of Alaska
- District of Arizona
- Central District of California
- Eastern District of California
- Northern District of California
- Southern District of California
- District of Hawaii
The Supreme Court ruled that it is NOT a violation of 2nd Amendment Rights to deny guns to marijuana patients. The impact of that ruling has now begun to spread. It would seem the federal government thus far is standing by this. Special Agent Joshua E. Jackson of the U.S. Bureau of Alcohol, Tobacco, Firearms and Explosives in Washington D.C. states:
“There are no exceptions in federal law for marijuana used for medicinal or recreational purposes.”
And as far as things look now, there will be no change anytime soon to the federal government’s stance on marijuana. Especially with the current administration emphasizing so heavily a law and order approach to drug policy.
More States Against Marijuana and Guns
Even though there are 29 states and Washington D.C. that have voted to allow patients to have access to medical marijuana, several of these states are choosing to trade that opportunity for a shot at gun ownership. In fact, just this week a few state officials announced their own stance against allowing gun owners to be medical marijuana patients.
In a move that spurred a backlash of viral videos and other reports, Hawaii took a bold step in this effort. Last week the Honolulu Police Department sent letters to medical marijuana users saying that they will need to turn in their weapons within 30 days of receipt. According to Leafly, a copy of one of these letters states:
“Your medical marijuana use disqualifies you from ownership of firearms and ammunition.”
However, the letter also apparently says that the medical marijuana patients can get their firearms back. The stipulation being they would need a doctor’s clearance to do so.
A similar situation happened in Pennsylvania. The state police director of the Bureau of Records and Identification, Major Scott C. Price, made an announcement on Tuesday stating:
“So, in fact, an individual who is issued a medical marijuana card in Pennsylvania who is a user of medical marijuana, that individual would be prohibited from purchasing or technically possession of a firearm under federal law.”
So Pennsylvania won’t allow people to even be in possession of a firearm at any time with a medical marijuana card.
Ohio’s medical marijuana program becomes operation in September of 2018. Information from industry analysts estimate that 24% of the state’s population have qualifying conditions; that’s 2.8 million Ohioans. But just this week it was announced that people in the Buckeye State who register to legally use marijuana for medicinal purposes will also be prohibited from possessing firearms.
According to the ATF letter from back in 2011, marijuana users are also prohibited from:
- Possessing firearms or ammunition
So anyone in Ohio who is applying to purchase a gun from a licensed dealer must sign a form attesting her or she is not “an unlawful user of, or addicted to, marijuana or any depressant, stimulant, narcotic drug, or any other controlled substance.”
Under federal law, lying on the form is a felony punishable by up to 10 years in prison. Even Joe Eaton, southwest spokesman for the Buckeye Firearms Association says they are confused at this point,
““There is definitely a conflict between the state laws and the federal laws,”
Some Ohio law enforcement officials are also unsure at this point how to enforce these situations as of the moment, and are depending on their prosecutors to provide more clarification through the conflict with state and federal law.
Will Marijuana Users Go Molon Labe?
For those unfamiliar with the term, molon labe is Greek for “come and take [them]”. This declaration has been repeated by many generals and politicians to express an army’s or nation’s determination not to surrender. The motto ΜΟΛΩΝ ΛΑΒΕ is on the emblem of the I Army Corps of Greece and the Second Infantry Division of Cyprus, and is also the motto of United States Special Operations Command Central (SOCCENT). The expression “Come and take it” was a slogan in the Texas Revolution.
It is also a popular choice of words for many 2nd Amendment advocates.
The question becomes, how will the hardcore 2nd Amendment supporters react to this ruling against medical marijuana and guns? Some actually believe this may actually inspire the National Rifle Association (NRA) to become pro-medical marijuana at the federal level. Will this kind of shift in support turn the tide?
Will avid gun owners come out in strong opposition to taking away guns from medical marijuana patients, or will they agree that drug use should disqualify them from owning or possessing weapons and ammunition?
How should authorities proceed? Is this a safe political sit rep or another war of opinions waiting to happen?
Treating Marijuana Abuse
Whether or not you support gun ownership of medical marijuana patients, we should all be able to get behind having treatment resources for anyone who struggles with substance abuse.
Marijuana, much like any other substance, can be abused and have an adverse impact on the overall quality of life for many people. No matter what the legal status of any drug, it can still have a negative impact on people who grapple with substance use disorder. We know this all too well, as plenty of prescription medications helped create the opioid crisis in America.
There still needs to be resources available to help people who suffer from abuse. Supporting addiction recovery means breaking the stigma and offering holistic and effective solutions. Palm Healthcare Company is here to help. If you or someone you love is struggling, please call toll-free now.
CALL NOW 1-800-951-6135